Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Jan;53(1):76–83. doi: 10.1136/jcp.53.1.76

Quantitative molecular virology in patient management

W Preiser 1, B Elzinger 1, N Brink 1
PMCID: PMC1731057  PMID: 10767862

Full Text

The Full Text of this article is available as a PDF (135.7 KB).

graphic file with name 99417.f1.jpg

Open in a new tab

Figure 1 Principle of the enzyme linked oligonucleotide assay (ELONA) for quantification of PCR products. AP, alkaline phosphatase; B, biotin; PCR, polymerase chain reaction; SA, streptavidin.

graphic file with name 99417.f2.jpg

Open in a new tab

Figure 2 Signal amplification: hybrid capture assay.

graphic file with name 99417.f3.jpg

Open in a new tab

Figure 3 Signal amplification: branched DNA assay.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed M. M., Mutimer D. J., Martin B., Elias E., Wilde J. T. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders. Haemophilia. 1999 Jan;5(1):49–55. doi: 10.1046/j.1365-2516.1999.00189.x. [DOI] [PubMed] [Google Scholar]
  2. Baker B. L., Di Bisceglie A. M., Kaneko S., Miller R., Feinstone S. M., Waggoner J. G., Hoofnagle J. H. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology. 1991 Apr;13(4):632–636. [PubMed] [Google Scholar]
  3. Berger A., Braner J., Doerr H. W., Weber B. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology. 1998;41(1):24–34. doi: 10.1159/000024912. [DOI] [PubMed] [Google Scholar]
  4. Bowen E. F., Sabin C. A., Wilson P., Griffiths P. D., Davey C. C., Johnson M. A., Emery V. C. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS. 1997 Jun;11(7):889–893. doi: 10.1097/00002030-199707000-00008. [DOI] [PubMed] [Google Scholar]
  5. Cao Y., Krogstad P., Korber B. T., Koup R. A., Muldoon M., Macken C., Song J. L., Jin Z., Zhao J. Q., Clapp S. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med. 1997 May;3(5):549–552. doi: 10.1038/nm0597-549. [DOI] [PubMed] [Google Scholar]
  6. Cao Y., Qin L., Zhang L., Safrit J., Ho D. D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 1995 Jan 26;332(4):201–208. doi: 10.1056/NEJM199501263320401. [DOI] [PubMed] [Google Scholar]
  7. Churchill D., Weber J. Measurement of plasma HIV viral load--clinical applications. J Infect. 1999 May;38(3):147–150. doi: 10.1016/s0163-4453(99)90241-4. [DOI] [PubMed] [Google Scholar]
  8. Clark D. A., Ait-Khaled M., Wheeler A. C., Kidd I. M., McLaughlin J. E., Johnson M. A., Griffiths P. D., Emery V. C. Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol. 1996 Sep;77(Pt 9):2271–2275. doi: 10.1099/0022-1317-77-9-2271. [DOI] [PubMed] [Google Scholar]
  9. Dusheiko G. M., Khakoo S., Soni P., Grellier L. A rational approach to the management of hepatitis C infection. BMJ. 1996 Feb 10;312(7027):357–364. doi: 10.1136/bmj.312.7027.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fox J. C., Kidd I. M., Griffiths P. D., Sweny P., Emery V. C. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol. 1995 Feb;76(Pt 2):309–319. doi: 10.1099/0022-1317-76-2-309. [DOI] [PubMed] [Google Scholar]
  11. Garson J. A., Brillanti S., Whitby K., Foli M., Deaville R., Masci C., Miglioli M., Barbara L. Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Med Virol. 1995 Mar;45(3):348–353. doi: 10.1002/jmv.1890450320. [DOI] [PubMed] [Google Scholar]
  12. Garson J. A., Uhnoo I., Whitby K., Braconier J. H., Deaville R., Duberg A., Wallmark E., Wiström J., Goldin R. D., Spacey B. Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C. J Viral Hepat. 1997 Sep;4(5):325–331. doi: 10.1046/j.1365-2893.1997.00061.x. [DOI] [PubMed] [Google Scholar]
  13. Gor D., Sabin C., Prentice H. G., Vyas N., Man S., Griffiths P. D., Emery V. C. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant. 1998 Mar;21(6):597–605. doi: 10.1038/sj.bmt.1701139. [DOI] [PubMed] [Google Scholar]
  14. Hawkins A. E., Zuckerman M. A., Briggs M., Gilson R. J., Goldstone A. H., Brink N. S., Tedder R. S. Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J Virol Methods. 1996 Jun;60(1):81–88. doi: 10.1016/0166-0934(96)02048-4. [DOI] [PubMed] [Google Scholar]
  15. Ho D. D., Moudgil T., Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. doi: 10.1056/NEJM198912143212401. [DOI] [PubMed] [Google Scholar]
  16. Hodinka R. L. The clinical utility of viral quantitation using molecular methods. Clin Diagn Virol. 1998 May 1;10(1):25–47. doi: 10.1016/s0928-0197(98)00016-6. [DOI] [PubMed] [Google Scholar]
  17. Kidd I. M., Clark D. A., Ait-Khaled M., Griffiths P. D., Emery V. C. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis. 1996 Aug;174(2):396–401. doi: 10.1093/infdis/174.2.396. [DOI] [PubMed] [Google Scholar]
  18. Kidd I. M., Fox J. C., Pillay D., Charman H., Griffiths P. D., Emery V. C. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation. 1993 Oct;56(4):867–871. doi: 10.1097/00007890-199310000-00018. [DOI] [PubMed] [Google Scholar]
  19. Lock M. J., Griffiths P. D., Emery V. C. Development of a quantitative competitive polymerase chain reaction for human herpesvirus 8. J Virol Methods. 1997 Feb;64(1):19–26. doi: 10.1016/s0166-0934(96)02139-8. [DOI] [PubMed] [Google Scholar]
  20. Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, Todd J. A., Hoo B. S., Kokka R. P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995 Apr 15;122(8):573–579. doi: 10.7326/0003-4819-122-8-199504150-00003. [DOI] [PubMed] [Google Scholar]
  21. Mellors J. W., Rinaldo C. R., Jr, Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May 24;272(5265):1167–1170. doi: 10.1126/science.272.5265.1167. [DOI] [PubMed] [Google Scholar]
  22. Paccagnini S., Principi N., Massironi E., Tanzi E., Romanò L., Muggiasca M. L., Ragni M. C., Salvaggio L. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J. 1995 Mar;14(3):195–199. doi: 10.1097/00006454-199503000-00005. [DOI] [PubMed] [Google Scholar]
  23. Ragni M. V., Faruki H., Kingsley L. A. Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1;17(1):42–45. doi: 10.1097/00042560-199801010-00006. [DOI] [PubMed] [Google Scholar]
  24. Ravaggi A., Zonaro A., Mazza C., Albertini A., Cariani E. Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates. J Clin Microbiol. 1995 Feb;33(2):265–269. doi: 10.1128/jcm.33.2.265-269.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Riddler S. A., Breinig M. C., McKnight J. L. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994 Aug 1;84(3):972–984. [PubMed] [Google Scholar]
  26. Saag M. S., Holodniy M., Kuritzkes D. R., O'Brien W. A., Coombs R., Poscher M. E., Jacobsen D. M., Shaw G. M., Richman D. D., Volberding P. A. HIV viral load markers in clinical practice. Nat Med. 1996 Jun;2(6):625–629. doi: 10.1038/nm0696-625. [DOI] [PubMed] [Google Scholar]
  27. Semple M., Loveday C., Weller I., Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol. 1991 Sep;35(1):38–45. doi: 10.1002/jmv.1890350109. [DOI] [PubMed] [Google Scholar]
  28. Shearer W. T., Quinn T. C., LaRussa P., Lew J. F., Mofenson L., Almy S., Rich K., Handelsman E., Diaz C., Pagano M. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med. 1997 May 8;336(19):1337–1342. doi: 10.1056/NEJM199705083361901. [DOI] [PubMed] [Google Scholar]
  29. Smith D. B., Lawlor E., Power J., O'Riordan J., McAllister J., Lycett C., Davidson F., Pathirana S., Garson J. A., Tedder R. S. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. Vox Sang. 1999;76(3):175–180. doi: 10.1159/000031045. [DOI] [PubMed] [Google Scholar]
  30. Tovo P. A., Palomba E., Ferraris G., Principi N., Ruga E., Dallacasa P., Maccabruni A. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis. 1997 Nov;25(5):1121–1124. doi: 10.1086/516102. [DOI] [PubMed] [Google Scholar]
  31. Walsh K. M., Good T., Cameron S., Thorburn D., McCruden E. A., Mills P. R., Morris A. J. Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C. Liver. 1998 Jun;18(3):191–195. doi: 10.1111/j.1600-0676.1998.tb00149.x. [DOI] [PubMed] [Google Scholar]
  32. Whitby K., Garson J. A. Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. J Virol Methods. 1995 Jan;51(1):75–88. doi: 10.1016/0166-0934(94)00144-6. [DOI] [PubMed] [Google Scholar]
  33. Yamamoto M., Kimura H., Hironaka T., Hirai K., Hasegawa S., Kuzushima K., Shibata M., Morishima T. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol. 1995 Jul;33(7):1765–1768. doi: 10.1128/jcm.33.7.1765-1768.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES